vs
拜玛林制药（BMRN）与KinderCare Learning Companies, Inc.（KLC）财务数据对比。点击上方公司名可切换其他公司
拜玛林制药的季度营收约是KinderCare Learning Companies, Inc.的1.3倍（$874.6M vs $676.8M），KinderCare Learning Companies, Inc.净利率更高（0.7% vs -5.3%，领先6.0%），拜玛林制药同比增速更快（17.0% vs 0.8%），KinderCare Learning Companies, Inc.自由现金流更多（$62.6M vs $58.9M）
拜玛林制药是总部位于美国加利福尼亚州圣拉斐尔的生物技术企业，在美洲、亚洲、欧洲多地设有办事机构及生产设施，核心业务聚焦酶替代疗法研发，是全球首个推出Ⅰ型粘多糖贮积症治疗药物拉罗尼酶及苯丙酮尿症治疗药物的企业。
金德凯尔学习公司是1969年成立的美国营利性早教与托育机构运营商，总部位于俄勒冈州波特兰市，服务覆盖全美39个州及华盛顿哥伦比亚特区，目前在全美拥有超1250家教学点，在读儿童约20万人，面向出生6周至12岁的儿童提供教育项目，是俄勒冈州第三大私营企业。
BMRN vs KLC — 直观对比
营收规模更大
BMRN
是对方的1.3倍
$676.8M
营收增速更快
BMRN
高出16.2%
0.8%
净利率更高
KLC
高出6.0%
-5.3%
自由现金流更多
KLC
多$3.7M
$58.9M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $874.6M | $676.8M |
| 净利润 | $-46.6M | $4.5M |
| 毛利率 | 68.5% | — |
| 营业利润率 | -5.1% | 3.9% |
| 净利率 | -5.3% | 0.7% |
| 营收同比 | 17.0% | 0.8% |
| 净利润同比 | -137.3% | -67.4% |
| 每股收益（稀释后） | $-0.22 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BMRNKLC
| Q4 25 | $874.6M | — | ||
| Q3 25 | $776.1M | $676.8M | ||
| Q2 25 | $825.4M | $700.1M | ||
| Q1 25 | $745.1M | $668.2M | ||
| Q4 24 | $747.3M | $647.0M | ||
| Q3 24 | $745.7M | $671.5M | ||
| Q2 24 | $712.0M | — | ||
| Q1 24 | $648.8M | — |
净利润BMRNKLC
| Q4 25 | $-46.6M | — | ||
| Q3 25 | $-30.7M | $4.5M | ||
| Q2 25 | $240.5M | $38.6M | ||
| Q1 25 | $185.7M | $21.2M | ||
| Q4 24 | $124.9M | $-133.6M | ||
| Q3 24 | $106.1M | $14.0M | ||
| Q2 24 | $107.2M | — | ||
| Q1 24 | $88.7M | — |
毛利率BMRNKLC
| Q4 25 | 68.5% | — | ||
| Q3 25 | 82.0% | — | ||
| Q2 25 | 81.8% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 81.8% | — | ||
| Q3 24 | 74.7% | — | ||
| Q2 24 | 81.7% | — | ||
| Q1 24 | 80.7% | — |
营业利润率BMRNKLC
| Q4 25 | -5.1% | — | ||
| Q3 25 | -6.0% | 3.9% | ||
| Q2 25 | 33.5% | 9.8% | ||
| Q1 25 | 30.0% | 7.3% | ||
| Q4 24 | 21.6% | -13.8% | ||
| Q3 24 | 15.3% | 8.1% | ||
| Q2 24 | 16.9% | — | ||
| Q1 24 | 13.6% | — |
净利率BMRNKLC
| Q4 25 | -5.3% | — | ||
| Q3 25 | -4.0% | 0.7% | ||
| Q2 25 | 29.1% | 5.5% | ||
| Q1 25 | 24.9% | 3.2% | ||
| Q4 24 | 16.7% | -20.6% | ||
| Q3 24 | 14.2% | 2.1% | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | 13.7% | — |
每股收益（稀释后）BMRNKLC
| Q4 25 | $-0.22 | — | ||
| Q3 25 | $-0.16 | $0.04 | ||
| Q2 25 | $1.23 | $0.33 | ||
| Q1 25 | $0.95 | $0.18 | ||
| Q4 24 | $0.65 | $-1.17 | ||
| Q3 24 | $0.55 | $0.15 | ||
| Q2 24 | $0.55 | — | ||
| Q1 24 | $0.46 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $174.7M |
| 总债务越低越好 | — | $930.9M |
| 股东权益账面价值 | $6.1B | $931.2M |
| 总资产 | $7.6B | $3.9B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资BMRNKLC
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $174.7M | ||
| Q2 25 | $1.2B | $119.0M | ||
| Q1 25 | $1.0B | $131.3M | ||
| Q4 24 | $942.8M | $62.3M | ||
| Q3 24 | $675.4M | $137.2M | ||
| Q2 24 | $972.1M | — | ||
| Q1 24 | $747.0M | — |
总债务BMRNKLC
| Q4 25 | — | — | ||
| Q3 25 | — | $930.9M | ||
| Q2 25 | — | $926.5M | ||
| Q1 25 | — | $927.4M | ||
| Q4 24 | — | $926.0M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BMRNKLC
| Q4 25 | $6.1B | — | ||
| Q3 25 | $6.1B | $931.2M | ||
| Q2 25 | $6.0B | $924.3M | ||
| Q1 25 | $5.8B | $884.9M | ||
| Q4 24 | $5.7B | $864.5M | ||
| Q3 24 | $5.4B | $235.6M | ||
| Q2 24 | $5.3B | — | ||
| Q1 24 | $5.1B | — |
总资产BMRNKLC
| Q4 25 | $7.6B | — | ||
| Q3 25 | $7.6B | $3.9B | ||
| Q2 25 | $7.5B | $3.8B | ||
| Q1 25 | $7.1B | $3.7B | ||
| Q4 24 | $7.0B | $3.6B | ||
| Q3 24 | $6.9B | $3.7B | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $6.9B | — |
负债/权益比BMRNKLC
| Q4 25 | — | — | ||
| Q3 25 | — | 1.00× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 6.42× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.6M | $100.8M |
| 自由现金流经营现金流 - 资本支出 | $58.9M | $62.6M |
| 自由现金流率自由现金流/营收 | 6.7% | 9.2% |
| 资本支出强度资本支出/营收 | 4.7% | 5.6% |
| 现金转化率经营现金流/净利润 | — | 22.15× |
| 过去12个月自由现金流最近4个季度 | $725.0M | — |
8季度趋势，按日历期对齐
经营现金流BMRNKLC
| Q4 25 | $99.6M | — | ||
| Q3 25 | $368.7M | $100.8M | ||
| Q2 25 | $185.3M | $35.0M | ||
| Q1 25 | $174.4M | $98.4M | ||
| Q4 24 | $185.6M | — | ||
| Q3 24 | $221.5M | — | ||
| Q2 24 | $118.8M | — | ||
| Q1 24 | $47.0M | — |
自由现金流BMRNKLC
| Q4 25 | $58.9M | — | ||
| Q3 25 | $340.2M | $62.6M | ||
| Q2 25 | $168.2M | $671.0K | ||
| Q1 25 | $157.6M | $75.1M | ||
| Q4 24 | $166.1M | — | ||
| Q3 24 | $203.0M | — | ||
| Q2 24 | $97.4M | — | ||
| Q1 24 | $20.9M | — |
自由现金流率BMRNKLC
| Q4 25 | 6.7% | — | ||
| Q3 25 | 43.8% | 9.2% | ||
| Q2 25 | 20.4% | 0.1% | ||
| Q1 25 | 21.2% | 11.2% | ||
| Q4 24 | 22.2% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 3.2% | — |
资本支出强度BMRNKLC
| Q4 25 | 4.7% | — | ||
| Q3 25 | 3.7% | 5.6% | ||
| Q2 25 | 2.1% | 4.9% | ||
| Q1 25 | 2.3% | 3.5% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 4.0% | — |
现金转化率BMRNKLC
| Q4 25 | — | — | ||
| Q3 25 | — | 22.15× | ||
| Q2 25 | 0.77× | 0.91× | ||
| Q1 25 | 0.94× | 4.65× | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 2.09× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 0.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMRN
| VOXZOGO | $273.4M | 31% |
| VIMIZIM | $205.5M | 24% |
| PALYNZIQ | $125.3M | 14% |
| NAGLAZYME | $120.2M | 14% |
| Other | $49.4M | 6% |
| ALDURAZYME | $49.4M | 6% |
| KUVAN | $23.3M | 3% |
| Royalty And Other | $15.2M | 2% |
| ROCTAVIAN | $12.8M | 1% |
KLC
| Early Childhood Education Centers | $627.0M | 93% |
| Before And After School Sites | $49.8M | 7% |
